Bacteriophage ZCSE2 is a Potent Antimicrobial against Salmonella enterica Serovars: Ultrastructure, genomics and efficacy by Mohamed, Ahmed et al.
  
Viruses 2020, 12, 424; doi:10.3390/v12040424 www.mdpi.com/journal/viruses 
Article 
Bacteriophage ZCSE2 is a Potent Antimicrobial 
Against Salmonella enterica Serovars: Ultrastructure, 
Genomics and Efficacy 
Ahmed Mohamed 1, Omar Taha 1,†, Hesham M. El-Sherif 2,3,†, Phillippa L. Connerton 4,  
Steven P.T. Hooton 4, Nabil D. Bassim 3, Ian F. Connerton 4,* and Ayman El-Shibiny 1,5,* 
1 Center for Microbiology and Phage Therapy, Biomedical Sciences, Zewail City of Science and Technology, 
Giza 12578, Egypt; ahmed.mostafa.taha@gmail.com (A.M.); p-okhaled@zewailcity.edu.eg (O.T.) 
2 Mechanical Design and Production Engineering Department, Faculty of Engineering, Cairo University, 
Giza 12613, Egypt; elsherih@mcmaster.ca 
3 Materials Science and Engineering Department, McMaster University, 1280 Main Street West,  
Hamilton, ON L8S 4L8, Canada; bassimn@mcmaster.ca 
4 Division of Microbiology, Brewing and Biotechnology, School of Biosciences, University of Nottingham, 
Loughborough LE12 5RD, UK; pippa.connerton@nottingham.ac.uk (P.L.C.); 
sbzsph@exmail.nottingham.ac.uk (S.P.T.H.) 
5 Faculty of Environmental Agricultural Sciences, Arish University, Arish 45615, Egypt 
* Correspondence: ian.connerton@nottingham.ac.uk (I.F.C.); aelshibiny@zewailcity.edu.eg (A.E-S.) 
† These authors contributed equally to this work. 
Received: 21 January 2020; Accepted: 7 April 2020; Published: 9 April 2020 
Abstract: Developing novel antimicrobials capable of controlling multidrug-resistant bacterial 
pathogens is essential to restrict the use of antibiotics. Bacteriophages (phages) constitute a major 
resource that can be harnessed as an alternative to traditional antimicrobial therapies. Phage ZCSE2 
was isolated among several others from raw sewage but was distinguished by broad-spectrum 
activity against Salmonella serovars considered pathogenic to humans and animals. Lytic profiles of 
ZCSE2 against a panel of Salmonella were determined together with low temperature activity and 
pH stability. The morphological features of the phage and host infection processes were 
characterized using a combination of transmission electron and atomic force microscopies. Whole 
genome sequencing of ZCSE2 produced a complete DNA sequence of 53,965 bp. No known 
virulence genes were identified in the sequence data, making ZCSE2 a good candidate for phage-
mediated biological control purposes. ZCSE2 was further tested against S. Enteritidis in liquid 
culture and was observed to reduce the target bacterium to below the limits of detection from initial 
concentrations of 107–108 Colony Forming Units (CFU)/mL. With a broad host-range against 
pathogenic Salmonella serovars, phage ZCSE2 constitutes a potential tool against a major cause of 
human and animal disease. 
Keywords: bacteriophage; Salmonella; phage biocontrol; atomic force microscopy 
 
1. Introduction 
The global disease burden caused by Salmonella spp. represents a significant proportion of 
microbial infections acquired through the consumption of contaminated food and water. In the 
developed world, Salmonella infection usually presents as a self-limiting gastrointestinal infection, 
although antibiotic treatments may be required. Non-typhoidal Salmonella (NTS) can be attributed to 
93 million cases of gastrointestinal disease annually, of which 155,000 infections result in death [1]. 
Furthermore, invasive non-typhoidal Salmonella (iNTS) is associated with enhanced pathogenicity 
towards specific demographics in the developing world. Notably, the young, elderly or 
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immunocompromised are at risk from iNTS infections, with ≈3.4 million reported cases on an annual 
basis [2]. Approximately 388,000 deaths arise from iNTS infection in sub-Saharan Africa alone, and 
globally the reported mortality is greater than 681,000 per annum [3,4]. Most instances of NTS/iNTS 
disease are associated with the globally distributed zoonotic serovars Salmonella Typhimurium and 
Salmonella Enteritidis [5,6]. Antimicrobial resistance (AMR) is well-documented in Salmonella spp., 
with many isolates being identified as being resistant to multiple antibiotic classes [7]. 
In terms of global food security, foodborne disease arising from consumption of Salmonella-
contaminated products remains a serious public health issue. Intensive farming practices such as 
those employed by the poultry production industry provide the perfect environment for the 
development and spread of AMR. Investigating alternative antimicrobial agents for the control of 
Salmonella and other pathogenic bacteria in food production environments is therefore paramount. 
One promising strategy is the use of bacteriophages (phages). As a naturally occurring biological 
control agent, phages represent a valuable tool for the targeted removal of bacteria from the food 
chain and other environments. Phages can be highly specific in terms of the target bacterial host and 
are ubiquitous in the environment. Phages have the capacity to self-replicate at an infection focal 
point at the expense of the host bacterial population. Such properties make phages a viable option 
for the decontamination of Salmonella in food production environments, and with the potential to 
extend therapeutic applications into clinical settings [8–12]. Many studies have shown that phage 
biocontrol of Salmonella can be achieved, and with products such as SalmoFresh (Intralytix Inc.) and 
Salmonelex/PhageGuard S (Micreos, BV) being marketed as food processing agents, it is evident that 
such approaches are efficacious. 
Ensuring constituents of phage treatments conform to safety requirements is far from trivial [13]. 
Undesirable traits including the ability of temperate phages to integrate into bacterial chromosomes 
or potential transduction of genes during infection events can be avoided through careful analysis of 
candidate phages in the laboratory. Obtaining complete genome sequences is also a prerequisite for 
phages being used in laboratory studies and beyond. Environmental stability of phages is also an 
important factor to consider. Some phages may only retain activity within a given pH range, which 
may limit their use in certain applications; however, for storage purposes, retaining phage infectivity 
following long-term storage in neutral buffers is essential. 
Complementary to the standard phage experiments that are used to monitor lifecycles, new 
approaches are becoming available that allow visualization of phage interactions with their microbial 
hosts. Advances in techniques such as atomic force microscopy (AFM) have allowed the infection 
process and lifecycle characteristics of phage AP22 during lytic growth on Acinetobacter baumannii to 
be visualized [14]. AFM was used to determine phage morphology, estimate the phage latent period, 
and further allowed detection of morphological changes at different stages of the lytic cycle by 
monitoring host cell adsorption. Various AFM scanning modes can be applied to study phages [15]. 
The non-contact mode of AFM is preferred in imaging phages because it provides no physical 
interaction between the sample and the scanning tip. However, the contact mode can be applied to 
study the mechanics of phages and used to monitor the infection process [16]. AFM peak-force mode 
has been used to manipulate phages using a chemically functionalized AFM tip [17]. 
The current paper aimed to characterize a novel virulent phage ZCSE2 that appears to be a 
representative of a phage class that has antimicrobial potential against multiple Salmonella serovars 
but for which little genetic or structural information is available. We used TEM and AFM imaging to 
examine the infection characteristics of the phage to establish the suitability for biocontrol 
applications. 
2. Materials and Methods 
2.1. Bacterial Strains and Growth Media 
Studies were conducted using multidrug-resistant Salmonella Enteritidis WT (Platten) obtained 
from The University of Nottingham (United Kingdom), where it was used in previous studies [8]. 
Stocks were maintained in 20% (v/v) glycerol at −80 °C until needed. Bacterial strains were grown on 
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Tryptic Soy agar (TSA; Oxoid, England) overnight at 37 °C and phage infections were carried out in 
Tryptic Soya broth (TSB; Oxoid, England) at 37 °C with shaking. 
2.2. Antibiotic Sensitivity Test 
The resistance profile of S. Enteritidis WT (Platten) was determined using a panel of antibiotics 
(Oxoid, England) representative of those administered to humans and animals (Table 1). 
Antimicrobial sensitivity testing was performed using the disk diffusion methods in accordance with 
the National Committee for Clinical Standards guidelines [18]. 
2.3. Bacteriophage Isolation, Amplification, and Purification 
Phages were isolated from environmental samples taken from waterways in El-Marg, Cairo, 
Egypt. S. Enteritidis WT (Platten) was used as a host bacterial strain for phage isolation. Phage plaques 
were purified by repeated single plaque isolation using sterile micropipette tips for a minimum of three 
rounds to obtain pure phage stocks [19]. All isolated phages were amplified to generate high-titer stocks 
as follows: 100 mL of host bacterium (107 CFU/mL) was infected with phages at a multiplicity of 
infection of 0.1 and allowed to lyse bacteria overnight in TSB (Oxoid, United Kingdom) at a temperature 
of 37 °C on an orbital shaker at 120 rpm [20]. Lysates were centrifuged at 6400× g for 15 min at 4 °C to 
remove remaining bacterial cells. The supernatant containing phages was then centrifuged for at 
15,300× g for 1 h at 4 °C. Phage pellets were resuspended in SM buffer (100 mM MgSO4/7H2O; 10 mM 
NaCl; 50 mM TrisHCl; pH 7.5) prior to filtration with 0.22 µm syringe filters (Chromtech, Taiwan). 
Phage titers were determined using standard double-agar overlay plaque assays [21]. Briefly, a single 
bacterial colony was picked using a sterile loop and used to inoculate TSB prior to incubation at 37 °C 
with shaking for several hours. From this culture, 100 µL was added to 3 mL of 1% Bacto top agar in 
Ok TSB (≈55 °C) prior to pouring onto TSA plates. After solidification, 10 µl aliquots of 10-fold serial-
diluted ZCSE2 were spotted in triplicate onto the bacterial lawn. Phage titers were calculated following 
overnight incubation at 37 °C. 
2.4. Lytic Profile of Isolated Phages 
Isolated phages were tested against an in-house panel of 25 Salmonella serovars. Criteria for 
selection involved identifying phages displaying a broad range of lysis against the Salmonella panel, 
alongside the ability to produce clear plaques on the host bacterium. Using double agar overlay 
plaque assays as described above, the lytic profile of isolated phages was determined against a panel 
of Salmonella strains shown in Table 2. Initial phage titers applied to lawns were not less than 109 
plaque forming units (PFU)/mL in 10 µL per spot equating to a routine test dilution of 107 PFU. The 
lytic activity of phages was determined on the basis of zones of clear lysis. 
2.5. Efficiency of Plating 
Over eight decimal dilutions, bacteriophage ZCSE2 was tested in triplicate against all the 
susceptible bacterial isolated that were lysed in spot assays as previously described [22]. Using the 
same conditions as spot test, 200 microliters of bacterial isolates in Log-phase were added to top agar 
at a temperature of 55°C. The top agar containing bacteria was added to Petri dishes of TSA and 
allowed to set and dry, before 10 L of serially diluted phage were dispensed onto the surface and 
the plates were incubated overnight at 37 °C. Efficiency of plating (EOP) was then calculated as the 
average PFU on target bacteria/average PFU on host bacteria. 
2.6. Phage Genome Size Determination Using (PFGE) 
DNA was prepared from phage ZCSE2 (1010 PFU/mL) for genome size determination by PFGE 
[23]. Briefly, ZCSE2 was suspended in 1.2% agarose plugs prior to digestion with lysis buffer (0.2% 
w/v SDS; 1% w/v N-lauryl sarcosine; 100 mM EDTA; 1 mg/mL proteinase K), overnight at 55 °C. 
Following washing, 2 mm slices of agarose-containing DNA were inserted into the wells of a 1% w/v 
agarose gel. The gel was run by using a Bio-Rad CHEF DRII system, in 0.5 × Tris-borate-EDTA, for 
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18 h at 6 V/cm with a switch time of 30 to 60 s. The size of the genome was determined by comparison 
to standard concatenated lambda DNA markers (Sigma Aldrich, Gillingham, United Kingdom). 
2.7. In Vitro ZCSE2 Lytic Activity 
The survival of a growing culture of S. Enteritidis WT (Platten) in the presence of ZCSE2 phage 
at multiplicities of infection (MOI) of 0.1, 1, and 10 PFU/CFU was estimated in comparison to 
uninfected bacterial control (phage-free samples) at 37 °C [24]. Phage infective centers (IC) and plaque 
forming units (PFU) were also estimated at different time intervals post addition (0, 5, 10, 20, 30, 40, 
60, 90, 120, and 180 min). IC is the amount of free phage particles already released from the bacterial 
cells, without adding chloroform, whereas PFU describes the amount of nascent phage both inside 
and outside the bacterial cell. Briefly, two flasks were filled with either bacterial culture at a given 
concentration (control) or with bacterial culture at the same concentration and bacteriophage 
matching the desired MOI (Test). At every time interval, titer of bacterial control (B), bacterial 
survival (BS) IC and PFU were simultaneously estimated. Bacterial titer were determined using the 
Miles and Misra method [25], whereas phage titer was estimated using double-agar overlay plaque 
assays by adding chloroform to the aliquot to be estimated in case of PFU determination, or not 
adding chloroform to calculate the IC. 
2.8. Bacteriophage Insensitive Mutant Frequency 
The frequency of insensitive mutants was evaluated as follows. Phages were used to infect 
bacterial cultures at a multiplicity of infection (MOI) of 100 and incubated for 10 min at 37 °C. The 
infected cultures were serially diluted, and the survivor frequency estimated as the CFU of survival 
colonies per CFU of initial colonies after overnight incubation at 37 °C [26]. Experiments were 
performed in triplicate and standard deviations were calculated. The surviving colonies were picked, 
and from these the bacteriophage-insensitive mutants (BIM) were established by plaque formation 
on bacterial lawns. 
2.9. ZCSE2 pH Stability 
The viability of ZCSE2 at different pH values (2–9) was determined by enumerating the phage 
titer as previously described after 1 h incubation of a 10 log10 PFU/mL suspension in a range of SM 
buffer. The range of pH of SM buffer was adjusted by using NaOH or HCl. 
2.10. ZCSE2 Activity at 4°C 
The antimicrobial effect of ZCSE2 was investigated at low temperature by incubating the phage 
with Salmonella Enteritidis WT (Platten) at 4 °C. The bacterial cells were allowed to grow in TSB to 
≈107 CFU/mL and then acclimated at 4 °C for 10 min before the addition of ZCSE2 at MOI 10. 
Following incubation at 4 °C, samples were collected at 0, 2, 4, and 24 h to enumerate the number of 
phages (PFU/mL) and bacterial survivors (CFU/mL), as described above. 
2.11. ZCSE2 Genome Sequencing 
A high titer stock of ZCSE2 (≈1010 PFU/mL) was prepared as described above. To obtain ZCSE2 
genomic DNA, phages were initially treated with proteinase K (100 μg/mL in 10 mM EDTA (pH 8)). 
DNA was extracted from the preparation using DNA Wizard Kit (Promega, United Kingdom) 
according to the manufacturer’s instructions. Library preparation of ZCSE2 genomic DNA followed 
the Illumina Nextera tagmentation protocol (Illumina, Cambridge, United Kingdom) and the library 
sequenced using the Illumina v3 sequence cassette for 600 cycles on the MiSeq platform. The data 
were composed of 3.1 million paired-end sequence reads with lengths of 250 bp. De novo assembly 
of sequence reads was performed using CLC Genomics Workbench version 11.0.1 (Qiagen, Aarhus, 
Denmark). Assembled reads yielded a complete double-stranded DNA ZCSE2 genome of 53,965 bp 
(coverage around 7000-fold). Gene predictions were made using PHASTER [27] and HHpred [28] to 
identify putative open reading frames (ORFs), followed by manual curation and polishing with 
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Artemis and BLAST (non-reductive NCBI databases). The sequence is available under the GenBank 
accession number MK673511. Bacteriophage genome sequence alignments, average nucleotide 
identities, and phylogenetic relationships were calculated using CLC Genomics Workbench 20.0.3. 
2.12. Morphology Investigation by Transmission Electron Microscopy (TEM) 
2.12.1. TEM Device Specification and Examination Conditions 
Preliminary sample screening was performed using a Philips CM12 microscope at medium 
magnifications at 120 KeV accelerating voltage using a LaB6 electron gun with parallel illumination 
and minimized current. The images were collected using an ORIUS SC600 CCD camera with 2.7k × 
2.7k pixel size. 
After screening, candidate ZCSE2 bacteriophage particles were imaged using an FEI Titan 80–
300 Cubed transmission electron microscope (located in the Canadian Centre for Electron 
Microscopy, Hamilton, Canada) equipped with a monochromator and double hexapole-based 
spherical aberration correctors in both the probe and the image forming lenses. The Titan microscope 
operated at an accelerating voltage of 80 keV. Images were acquired in scanning TEM mode at 19.1 
mrad conversion angle and 91 cm camera length using both bright field (BF) and high annular angle 
dark field (HAADF) detectors with 2048 × 2048 pixel size. The imaging conditions were selected to 
reduce possible electron beam damage of the samples and the electron probe dose lowered to be less 
than 70 e−/Å2S and 4 µS dwell time. Several TEM images at low and high magnification were taken 
from the sample at different locations of the TEM copper grid to locate the phages and observe the 
most repeatable morphology. In addition to the scanning transmission electron microscopy (STEM) 
mode, the Titan microscope was also used in TEM mode using parallel illumination in screening and 
navigation using a US1000FTXP CCD camera. 
2.12.2. TEM Sample Preparation 
The ZCSE2 was centrifuged at 12,000 rpm for 30 min and resuspended in 100 µL SM buffer. 
Uranyl acetate, 10 µL of 1% w/v solution, was used as a negative stain on a TEM carbon lacey grid at 
room temperature. Residual mixture was removed and, finally, the sample was exposed to light from 
a warm lamp at 30 cm distance for 15 min at room temperature. 
2.12.3. TEM data Analysis 
Several TEM images at high magnification were taken for phages at different locations from 
three TEM copper grids. To calculate statistical values of the phage main dimensions, ImageJ 
program (open source) was used to measure the phage head diameter (D), phage tail diameter (d), 
and the total phage length (L) to calculate the average and standard deviation for these dimensions. 
2.13. AFM Sample Preparation 
For AFM analyses, ZCSE2 with titer of 109 PFU/mL was used. Overnight culture of S. Enteritidis 
WT (Platten) was diluted in fresh liquid culture and incubated for 90 min at 37 °C. The culture was 
then subdivided into two parts: uninfected control and infected (MOI 50). At different time intervals 
varying from 1 to 120 min, aliquots of samples were taken and investigated with AFM. Samples of 
either S. Enteritidis cells or mixture with ZCSE2 phage were diluted 10-fold by adding 9 mL of milli-
Q water to 1 mL of sample. A drop of 5 µL was dispensed on a highly oriented pyrolytic graphite 
(HOPG) surface and allowed to dry in a laminar flow hood for 10 min. Residual liquid was removed. 
The process was repeated 3–5 times before AFM examination. 
2.13.1. AFM Device Specification 
An AFM neaSNOM microscope (nea-Spec GmbH, Munich, Germany) with 0.2 nm resolution 
was used to perform both surface topology and phase imaging of bacteria and phages. AFM probes 
from NANO-WORLD of 45 x 4.6 µm cross section and 160 µm length with 285 KHz average 
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resonance frequency were used. The probes possess a thick coating layer of a 23 nm of platinum-
iridium on both sides of the cantilever. The radius of the probe tip is assumed to be less than 10 nm 
by the manufacturer. However, the radius may change due to particle or liquid adhesion to the tip 
during the test. In order to optimize the image resolution, several images were taken from the region 
of interest at different scan speeds and scan sizes. All AFM images were maintained with pixel times 
more than 5 ms/pixel to acquire strong signal. 
2.13.2. Post-Processing of AFM Images 
Raw data of topology and phase imaging were processed by open source “Gwyddion” software 
Version 2.55 (http://gwyddion.net/download.php) [29]. The software was used to level the data by 
mean plane subtraction and to reduce minor scan defects and scan noise without affecting the 
physical dimensions of the images. These were used to plot cross sections and height distribution of 
AFM topology images. 
2.14. Statistical Analysis 
Test and control datasets were compared using Student’s t-test. A p-value of 0.05 or less was 
considered statistically significant in all cases. Analytical statistics were calculated using ANOVA 
with GraphPad PRISM software. 
3. Results 
3.1. Bacterial Sensitivity to Antibiotics 
To determine the antibiotic resistance of the bacteriophage host Salmonella Enteritidis WT 
(Platten), antibiotic sensitivity tests were performed using the disc diffusion method. Salmonella 
Enteritidis WT (Platten) was resistant to 10 different antibiotics, including cefotaxime, clarithromycin, 
and vancomycin, whereas it is intermediately resistant to the three antibiotics ciprofloxacin, 
azithromycin, and cefoxitin. The strain also showed sensitivity to another set of antibiotics, as noted 
in (Table 1). This demonstrated the high antibiotic resistance profile of the Salmonella Enteritidis WT 
(Platten) strain. 
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Table 1. Antibiotic susceptibility profile of Salmonella Enteritidis WT (Platten). 
Class Antibiotics Diameter of Inhibition Zone (cm) Results 
Cephalosporins 
Second 
generation 
Cefoxitin 2.2 Intermediate 
Cefaclor 0.8 Resistant 
Cephalosporins 
Third generation 
Cefotaxime 2.2 Resistant 
Chloramphenicol 2.9 Susceptible 
Ceftazidime 2.3 Susceptible 
Ceftriaxone 3.1 Susceptible 
Macrolides 
Clarithromycin 0.9 Resistant 
Erythromycin 0.8 Resistant 
Vancomycin 0 Resistant 
Azithromycin 1.4 Intermediate 
Quinolones 
Levofloxacin 3.4 Susceptible 
Ciprofloxacin 3.0 Intermediate 
Penicillins 
Piperacillin 2.5 Susceptible 
Oxacillin 0 Resistant 
Oxazolidinones Linezolid 0.8 Resistant 
Lincosamides Clindamycin 0 Resistant 
Nitrofurans Nitrofurantoin 1.3 Resistant 
Carbapenems Ertapenem 3.0 Susceptible 
Aminoglycosides Amikacin 1.9 Susceptible 
Aminocoumarin Novobiocin 1.2 Resistant 
Tetracyclines Tetracycline 2.8 Susceptible 
3.2. Lytic Profile and EOP of Isolated Bacteriophages 
Bacteriophages were isolated from sewage water using multidrug-resistant Salmonella 
Enteritidis WT (Platten) as host. Phage isolates were purified via successive rounds of plaque 
purification. Following this, testing was performed on different strains of S. enterica to select potential 
lytic phages. Phage ZCSE2 showed the highest capability of lysis against many strains compared to 
other phages (Table 2). ZCSE2 phage was capable of producing lysis zones (≥ 20 plaques) at the 
routine test dilution of 107 PFU on 24 out of 25 Salmonella strains representing 16 serotypes (Table 2). 
ZCSE2 demonstrated a potent antibacterial action against several multidrug-resistant (MDR) virulent 
Salmonella such as S. Typhimurium DT104 and S. Typhimurium U288 [8,30]. Notably, phages ZCSE4 
and ZCSE5 exhibited restricted host ranges and could not be easily propagated on the isolation host. 
These data indicated that ZCSE2 had broad-spectrum anti-Salmonella activity and was selected for 
further study. The ability of ZCSE2 to lyse multiple Salmonella serovars was further assessed by 
examining the efficiency of plating (EOP). The selected phage exhibited EOPs ≥0.5 for 19 of 22 
Salmonella isolates examined (Table S1). 
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Table 2. Lysis range of ZCSE2 phage. 
Salmonella Strains ZCSE2 ZCSE3 ZCSE4 ZCSE5 
S. Agama WT + + + − 
S. Togla Amersham 5.8.95 + − − + 
S. Amsterdam WT + − − − 
S. Typhimurium DT104 NCTC 13348 + + − − 
S. Atlanta NCTC 9986 + + + − 
S. Typhimurium LT2 + + − − 
S. Bareilly NCTC 5745 + + − − 
S. Typhimurium WT Rawlings + + − − 
S. Derby WT + + − − 
S. Typhimurium S21344 + + − − 
S. Enteritidis HOOO WT + + − − 
S. Typhimurium WT Turner + + − − 
S. Enteritidis WT (Platten) + + − − 
S. Typhimurium U288 + + − − 
S. Enteritidis SA029 + + − − 
S. Virchow WT + + + − 
S. Enteritidis WT Harrison + + − − 
S. Hadar WT + + + − 
S. Infantis NCTC 6903 + − − + 
S. Kedougou + − − + 
S. Kubacha WT + + − − 
S. Montevideo NCTC 5797 + − − − 
S. Montevideo WT + − − − 
S. Senftenburg WT − − − − 
S. Thompson NCTC 2252 + + − − 
+ indicates plaque formation, – indicates no plaque formation. 
3.3. Antibacterial Efficacy of ZCSE2 in Vitro 
To quantify the antibacterial lytic activity of ZCSE2, growing cultures of S. Enteritidis WT 
(Platten) were infected with ZCSE2 at different MOIs of 0.1, 1, and 10 over a period of 4 h. The 
infection and lysis characteristics, including time to lysis and burst size for ZCSE2, were quantified 
(Figure 1a–f). The period of infection to the onset of lysis was estimated to be in a range of 15 to 30 
min for each MOI. The estimate of burst size for MOI 0.1 was 155 PFU/CFU. Salmonella Enteritidis 
WT (Platten) was lysed by ZCSE2 at each MOI tested, with a MOI of 10 reducing viable bacteria from 
7.5 log10 CFU/mL to below the limit of detection (2 log10 CFU/mL) at 37 °C after 45 min (Figure 1e). 
Log10 reductions in bacterial counts compared to control were recorded after 60 min for MOIs 1 and 
0.1 PFU/CFU, and fell below the detection limit after 120 min. Notably, the bacterial populations did 
not recover over the 4 h course of the experiment. The data suggest that ZCSE2 is potent at high MOI 
and could eliminate the bacterial growth within an hour. 
Cultures of S. Enteritidis WT (Platten) were infected with ZCSE2 at MOI 100 at 37ºC for 10 min 
to permit adsorption before serial dilution and incubation overnight in order to estimate the 
frequency of the bacteria recovered that had evaded bacteriophage infection and lysis. Under these 
circumstances, the survivor frequency was 0.08 ± 0.03 (n = 3). One hundred isolates were recovered, 
and 26/100 proved resistant to ZCSE2 infection, giving an estimate of the BIM frequency as 0.02. 
Viruses 2020, 12, 424 9 of 20 
 
 
Figure 1. The kinetics of ZCSE2 infection of Salmonella Enteritidis WT (Platten) at 37 OC. (a,c,e) 
Bacterial counts for control- (◼) and phage-infected (⚫) cultures, where the dashed lines indicate 
when the viable count fell below the limit of detection of 2 log10 CFU/mL for Salmonella. (b,d,f) Phage 
titers for infective centers (log10 plaque forming units (PFU)/mL) (⚫; solid line) and nascent phage 
(log10 PFU/mL) (◼; dashed line). Panels (a) and (b) show a starting multiplicities of infection (MOI) 
0.1; panels (c) and (d) starting MOI 1; panels (e) and (f) starting MOI 10. 
3.4. Phage Genome Size Determination Using PFGE and Sequencing 
To characterize ZCSE2, the genome of ZCSE2 was determined by using PFGE. The result 
indicated ZCSE2 was likely a DNA phage with an estimated genome size of ≈50 kb. 
3.5. ZCSE2 Complete Genome Sequence 
The Illumina MiSeq platform was used to assemble a genome of 53,965 bp for phage ZCSE2. The 
sequence reads could be configured into a continuous circle consistent with a circularly permuted 
genome. However, we note the tagmentation protocol adopted for DNA sequence library preparation 
may not have provided the evidence required to identify genomic termini. Analysis of the nucleotide 
composition of ZCSE2 indicated a G+C content of 45.83%. A total of 78 putative open reading frames 
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were identified and annotated in the sequence data (accession number MK673511). Although 33 
ORFs were annotated as hypothetical proteins, it was possible to assign putative functions to 45 ORFs 
encoding phage structural proteins, DNA metabolic functions, and host recognition and lysis (Table 
3). In common with many bacteriophages, the major capsid proteins showed sequence conservation 
with phages infecting taxonomically related bacteria; in this case, phages infecting Salmonella and 
other Gram-negative bacterial species showed amino acid identities between 94–39%. No genes 
encoding virulence factors were identified during the annotation and analysis. At the nucleotide 
level, four Salmonella phages were found to be related to ZCSE2 following BlastN analysis of the non-
redundant database at NCBI: 54,894 bp UPF_BP2 (KX826077), 52,437 bp BP63 (KM366099), 50,936 bp 
LSE7621 (MK568062), and 52,474 bp vB_SenM_PA13076 (MF740800). Nucleotide identities of 85–87% 
were observed when comparing the genomes of phages UPF_BP2, BP63, LSE7621, and 
vB_SenM_PA13076 with coverages ranging between 69% and 74% of ZCSE2. Figure 2 presents the 
phylogenetic relationships of these phages referenced to genome sequences that represent genera 
within the Myoviridae family that were recorded as infecting Salmonella in the 2018b release of the 
International Committee on Taxonomy of Viruses. On the basis of average nucleotide identities from 
pairwise alignments, the genome sequences of ZCSE2 and sequence related phage fell within a clade 
that is distinct from the recognized genera of bacteriophage that replicate in Salmonella. However, we 
noted that the genome sequence of ZCSE2 showed divergence from other members of the clade. 
  
Viruses 2020, 12, 424 11 of 20 
 
Table 3. Phage ZCSE2 proteins with putative functions. 
Protein ID Chromosomal Loci (nt) Putative Function 
QBZ70504 1–978 Major capsid protein 
QBZ70505 1051–1425 HNH endonuclease 
QBZ70506 1455–1955 DCTP pyrophosphatase 
QBZ70507 1955–2455 DNA primase 
QBZ70508 2448–2825 Head-to-tail interface protein 
QBZ70510 3276–3896 Minor tail fiber 
QBZ70511 3911–6853 Tail protein 
QBZ70512 6923–7564 Head-to-tail interface protein 
QBZ70513 7577–9451 Sheath structural protein 
QBZ70514 9539–10,678 Cell adhesion protein 
QBZ70515 10,689–11,120 DNA helicase 
QBZ70516 11,137–11,565 Membrane-associated initiation of head vertex 
QBZ70517 11,616–11,750 RecA-like recombination protein 
QBZ70518 11,731–13,392 DNA polymerase 
QBZ70520 14,619–15,569 RegA-like translational repressor 
QBZ70521 15,559–16,203 Baseplate assembly V 
QBZ70522 16,212–16,583 Clamp-loader subunit 
QBZ70523 16,587–17,750 Sliding clamp DNA polymerase 
QBZ70524 17,743–18,396 RNA polymerase binding protein 
QBZ70525 18,389–19,738 Tail fiber 
QBZ70526 19,738–20,280 Tail fiber assembly protein 
QBZ70527 20,283–20,792 Tail fiber chaperone 
QBZ70528 20,894–21,157 dsDNA binding protein 
QBZ70529 21,201–21,677 Lysozyme 
QBZ70530 21,656–21,985 DUF2570 domain-containing protein 
QBZ70531 22,203–22,427c TraR/DksA family transcriptional regulator 
QBZ70533 22,711–24,681c DNA polymerase 1 
QBZ70534 24,678–25,676c DNA polymerase beta subunit 
QBZ70535 25,709–26,593c Thymidylate synthase 
QBZ70536 26,593–27,186 NTP pyrophosphohydrolase 
QBZ70541 28,955–30,628c ATP-RNA helicase 
QBZ70543 30,835–31,710c Cas4 family exonuclease 
QBZ70544 31,712–32,176c Deoxycytidylate deaminase 
QBZ70545 32,237–32,776c DUF669 domain-containing protein 
QBZ70546 32,881–33,771c σ factor for late transcription 
QBZ70550 35,919–36,215c Glyoxalase 
QBZ70552 36,284–36,616c Host-nuclease inhibitor protein 
QBZ70558 38,983–39,315 Glutaredoxin 
QBZ70559 39,290–41,824 Anaerobic NTP reductase small subunit 
QBZ70560 42,319–42,747 Protector of prophage-induced early lysis 
QBZ70574 47,327–47,998 Dihydrofolate reductase 
QBZ70575 47,995–48,495 Thymidylate kinase 
QBZ70579 50,055–51,503 Terminase large subunit 
QBZ70580 51,505–53,067 Portal protein 
QBZ70581 53,246–53962 Scaffold protein 
Nucleotide locations with suffix c indicate the reading frame is located on the complementary strand. 
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Figure 2. Phylogenetic relationships between Myoviridae infecting Salmonella. UPGMA (unweighted 
pair group method with arithmetic mean) tree based on average nucleotide identities (ANI) from 
pairwise comparisons of the genome sequence of ZCSE2 and bacteriophage genomes that,include 
reference genome sequences representing genera within the Myoviridae family that infect Salmonella 
(International Committee on Taxonomy of Viruses release 2018b). The bacteriophage DNA sequences 
are identified by their nucleotide database accession numbers. 
3.6. ZCSE2 pH Stability 
The ability to withstand a range of pH is one of the factors that could affect the applicability of 
phages. To determine the optimal pH for maximum efficacy of ZCSE2, phages were treated over a 
range of different pH values (2–9) and surviving titers were determined. Upon exposure to pH 3, the 
phage titer dropped below detection limit (3 log10 PFU) (Figure 3a). The maximum phage titer was 
recorded at pH 8 and declined at pH 9. 
(a)  
(b)  
Figure 3. Phage stability at (a) different pH values shown as means ± standard error. (b) Phage 
treatment of S. Enteritidis WT (Platten) at 4 °C. This chart shows the drop in bacterial counts after 2 
h of incubation with ZCSE2 at 4 °C. The solid circles “●” represent non-infected bacterial counts 
(CFU/mL), solid black squares “■” represent counts of bacteria treated with phage (CFU/mL), and the 
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solid triangles “▲” represent the phage titer (PFU/mL). The limits of detection were 2 log10 CFU/mL 
and PFU/mL for bacteria and phage, respectively. 
3.7. ZCSE2 Stability at Low Temperature 
To test if ZCSE2 could reduce the numbers of Salmonella at low temperature, as would be 
encountered in the chilled food chain, we tested its lytic activity at 4 °C, over a 24 h period. Figure 3b 
shows incubation of ZCSE2 with S. Enteritidis WT (Platten) at 4 °C and demonstrates a reduction of 
1 log10 CFU/mL in the bacterial count after 2 h of incubation in response to phage treatment compared 
to the untreated control (p = 0.01). The phage treated culture remained >1 log10 CFU/mL lower than 
the control over 24 h. The phage titer remained stable at 4 °C. 
3.8. ZCSE2 Characterization and Imaging Bacterial Lysis with TEM 
Parallel illumination TEM mode revealed the existence of negatively stained groups of the 
ZCSE2 phages (Figure 4a), from which a well-separated bacteriophage could be imaged at higher 
magnification (Figure 4b) using a double-corrected microscope in STEM mode. The STEM image 
revealed that ZCSE2 has a complex structure that corresponds with the dsDNA type (T-even phages) 
of the Myoviridae family with a characteristic elongated head, collar, tail tube, tail fibers, baseplate, 
and a spike. The same phage was also imaged using a STEM-HAADF detector and image-corrected 
electron beam in TEM mode in Figure 4c,d, respectively. It was observed that the STEM mode 
provided better resolution and contrast for the same feature due to the benefit of correction the 
spherical aberrations of the electron probe in both the probe forming and imaging planes. 
The contractile nature of the ZCSE2 tail is presented in Figure 4e, which shows a contracted tail 
sheath relative to the central tail tube. The contracted tail diameter was observed to have a lower 
diameter (13.1 nm) than the average values of the non-contracted tails (14.9 ± 2.7 nm) because of the 
expected contraction mechanism that combines both linear and rotational motions of the outer tail 
tube. Figure 4f illustrates the main dimensions of the ZCSE2 as measured from TEM images (see 
Figure S1 and Table S2). It shows that the phage had an approximate 1:1 ratio of the head length to 
the tail length, whereas the head diameter was a little more than twice the tail diameter, with a ratio 
of 2.3:1. In this study, the phage length was measured from the head to the spike without including 
the length of the fibers because these may be truncated in the image. 
ZCSE2-infected S. Enteritidis WT (Platten) cells were imaged using the transmission electron 
microscope in parallel illumination. At an early stage of infection process, phages became attached 
to the bacterial cell wall (Figure 5a) before the phages injected their DNA into the cell, and empty 
capsids could be observed as being attached to the cell wall (black arrows in Figure 5b,c). Post-
replication nascent phages were formed inside the infected cell (Figure 5b, white arrow) until rapture 
of the bacterial cell wall released multiple phages from the lysed bacteria (Figure 5d). 
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Figure 4. TEM micrographs and investigations of the ZCSE2 bacteriophage. (a) Image showing a 
group of three negatively stained phages acquired by parallel illumination in TEM mode using the 
Philips CM12 microscope. (b) Bright-field scanning transmission electron microscopy (BF-STEM) 
image acquired by the probe-corrected Titan microscope for an isolated ZCSE2 bacteriophage 
showing the main morphological components: long head, collar, tail tube, tail fibers, baseplate, and a 
spike. (c) STEM-high annular angle dark field (HAADF) image acquired simultaneously with the BF-
STEM image in STEM mode with the double-correction of the spherical aberration in both probe and 
imaging plans. (d) High-resolution TEM image of the same phage acquired with single-correction in 
the imaging plan only in TEM mode using a US1000FTXP CCD camera. (e) TEM image showing a 
fully contracted tail sheath with the core visible, where the contracted tail diameter (13.1 nm) was less 
than the average (14.9 ± 2.7 nm) of the uncontracted tail diameter, as expected, due to the squeezing 
of the helical tail tube. (f) Illustration figure showing the main dimensions of the ZCSE2 
bacteriophage, as measured from the TEM images acquired during screening the sample. 
Viruses 2020, 12, 424 15 of 20 
 
 
Figure 5. TEM images of different bacteria cells infected by the ZCSE2 phages. The images were 
contrasted to show (a) two ZCSE2 phages (black arrows) attached to the bacteria wall; (b) infected 
bacteria, but not yet lysed, with empty capsids (black arrow) attached to its wall, with the particles 
with dark contrast inside the bacteria (white arrow) representing nascent phages being formed in an 
earlier stage inside the bacteria; (c) a close up image showing an empty capsid attached to the bacteria 
wall and nascent phages inside; (d) a few mature phages (black arrows) surround a lysed bacteria 
with crumpled walls. 
3.9. ZCSE2 Characterization and Imaging Bacterial Lysis with AFM 
Atomic force microscopy imaging was carried out on a HOPG hydrophobic surface that 
maintains the water content to prevent damage over the course of the experiment [14,15]. Typically, 
the AFM examination was performed over 1–2 h incubation at 20 to 25 °C after dispensing bacteria 
and phages on the HOPG surface. Figure S2 illustrates how the AFM microscope scans the ZCSE2 
bacteriophage particle on an atomically flat highly oriented pyrolytic graphite (HOPG) surface. The 
AFM scanning profile reflects only the correct measurement of the phage head diameter relative to 
the flat surface. AFM scanning confirmed the morphology revealed by the TEM, and a phage head 
diameter of 46.4 nm was determined using the cross-section perpendicular to the phage head (Figure 
S3). AFM imaging of the host bacteria S. Enteritidis WT (Platten) revealed the dimensions of the 
bacillus (0.2 µm wide and 1.2 µm long) in the absence of infection (Figure S4). 
AFM examination of the ZCSE2 lytic cycle after incubation with S. Enteritidis WT (Platten) was 
undertaken using a group of four bacteria identified in an optical survey of the HOPG surface (see 
Figure S5). The 3D image presented in Figure 6a shows cells in the process of infection and phage-
mediated lysis. Figure 6b shows an AFM phase image collected simultaneously, where the color 
contrast in the AFM phase differentiates the lysis event at the surface of the bacterium [14]. Lysis is 
associated with the emergence of ZCSE2 phage, as indicated in the circle in Figure 6a. The maximum 
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AFM height of this phage was found to be 57 nm, as shown in the corresponding location of Figure 
6c, which is consistent with the phage dimensions measured by AFM and TEM. 
The height of the ruptured bacterium (profile 1, Figure 6e) measured in the cross-section was 
lower than the other three cells as a result of phage release after lysis, which accumulated to form the 
height measured in profile 2. The change in height was accompanied by a rougher surface compared 
to non-infected bacteria in the 2D and 3D and phase images (Figure 6b,d). The two cells in the center 
of the image also exhibited profiles that were rougher (profiles 3 and 4 in Figure 6d) than the cell at 
the top of the image (profile 5 in Figure 6d). The central two cells were infected and the surface 
roughness observed a consequence of late infection pre-cell rupture. 
 
Figure 6. Atomic force microscopy (AFM) analysis of bacterial lysis. (a) A 3D image of four cells on 
highly oriented pyrolytic graphite (HOPG) surface. The bacteria on the bottom-left was found to be 
ruptured and numbers of bacteriophages came out from it and attached to the neighbor bacteria. (b) 
AFM phase image of ruptured bacteria showed a difference in contrast between the raptured bacterial 
cell wall and the phages that emerge from the torn region. The difference in color of the phase image 
can be interpreted as a differences in the sample stiffness of bacteria and phages, which produced a 
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phase shift of the AFM probe vibration during scanning. (c) Cross-sectional profile of the 
bacteriophage indicated in the circle in panel (a), where the left and right inserts are respectively the 
2D and 3D AFM images of the bacteriophage. (d) 2D AFM image of the same site with the 
corresponding cross section lines. (e) Profiles of the cross-section lines in panel (d) show the height 
gradient related to the infection stage. Profile 1 is a lysed cell, profile 2 represents accumulated phages 
from the lysed cell, profiles 3 and 4 are infected cells, and profile 5 represents an uninfected cell. The 
raptured cell in the bottom-left section—profile 1—has the lowest height. It is also notable that the 
cells in the late infection stage have surface roughness and wrinkles. 
4. Discussion 
Developing alternative non-antibiotic biocontrol techniques for eliminating pathogenic 
microorganisms from clinical settings, agricultural production environments, and retail food 
products constitutes an important avenue of research in antimicrobial development [31]. Phages that 
conform to the criteria of being strictly lytic (virulent), have a broad target host-range, and display a 
high degree of efficacy against their microbial hosts are ideal candidates for phage therapy and 
biosanitization applications. Here, we report the structural and functional characteristics of a novel 
broad host-range Salmonella-specific bacteriophage ZCSE2. A combination of TEM and AFM were 
employed to determine morphological features of ZCSE2 and visualize the infection process using S. 
Enteritidis as the host strain. The genome sequence of ZCSE2 has few homologues in the database, 
but collectively the genomes of these bacteriophage are distinct from other genera of the Myoviridae 
and have the potential to form the basis for a new taxonomic subclass family (Figure 2). In planktonic 
growth, ZCSE2 was observed as reducing the target S. Enteritidis population to below the limits of 
detection (102 CFU/mL) when applied at MOIs greater than 1. 
Characterization of the ZCSE2 phage by TEM revealed the phage morphology and dimensions. 
Sub-nanometer spatial resolution (≈2.1 Å) was achieved using the probe-corrected STEM beam, 
which was higher than the uncorrected TEM in parallel illumination mode. The STEM images of 
ZCSE2 phage indicated that the phage was a dsDNA type from the Myoviridae family featuring a long 
crystal head and a contractile tail with a spike and tail fibers. The central tail fiber was observed when 
the outer tail tube fiber was contracted relative to its head. Structural similarities to the Myoviridae, 
notwithstanding the genome structure and sequence, indicated the fact that ZCSE2 is a member of a 
small group of novel phages, the structures and lifecycle of which have hitherto not been 
investigated. Snapshots of the lysis process were captured in TEM images due to the variations in the 
stage of infection. TEM images showed the capsids attached to the cell wall of the host bacteria and 
nascent phage production inside the cell. These observations were consistent with a virulent lifestyle 
and the suitability of the phage for biocontrol applications. 
An important advantage of the AFM technique is that it can efficiently examine biological 
samples in atmospheric pressure [17]. This gives privileges to the AFM technique to maintain 
hydration of biological samples in contrast to electron microscopy techniques that require vacuum 
and sample preparation using chemicals for fixing and staining the phages on the TEM grids. Despite 
the high vertical resolution of the AFM (0.2 nm), the measurements of the phage dimensions are only 
reliable for the phage head diameter. The phage head diameter measured by the vertical AFM 
resolution was within the distribution measured by TEM microscopy (Figure S1e). However, AFM 
measurement of the phage length can have artifacts due to the contractile nature of the ZCSE2 phage 
tail, in addition to the effect by the AFM probe radius on the lateral resolution direction. The probe 
radius adds extra length, which results in an overestimate along the phage axis, as shown in the 
model presented in Figure S2 and experimentally observed in Figure S3. The phage tail diameter is 
located within the range of vertical resolution but cannot be accurately measured because the tail 
orientation is not horizontally parallel to the HOPG flat surface. However, using the AFM, we were 
able to examine the lytic cycle and the effects on bacterial host dimensions. Infected bacteria were 
found to have less AFM height and a rough cell surface compared to a non-infected cell. Bacterial 
lysis was characterized by a decline of the cell height and the observation of phage release (the size 
suggests tens of virions) to propagate the infection of surrounding bacteria. 
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The ZCSE2 bacteriophage displayed high efficacy in reducing the counts of viable bacteria in 
vitro over a wide host range that included various Salmonella serovars. With the application of high 
concentrations of bacteriophages (MOI of 10), ZCSE2 was demonstrated to reduce the numbers of S. 
Enteriditis by ≥ 5.5 log10 CFU/mL. This reduction in viability was recorded over 40 min, which likely 
relates to the loss of host viability by a combination of infection and non-infectious killing by an 
established phenomenon called “lysis from without”, where many phages become absorbed to 
bacterial cells causing lysis without the release of new phages [32]. The use of high phage 
concentrations increases the chance of phage attaching to their host cells and, accordingly, 
significantly increases their effectiveness in reducing the numbers of target host over a short time 
period [9,33]. This is important because the use of single high dose treatment does not result in the 
generation of phage-resistant bacterial mutants, which is considered a limitation of phage therapy. 
We estimated the BIM frequency as ≈2%, which compares favorably with other bacteriophage 
therapy studies [34]. Bacteriophage ZCSE2 remained stable at a low temperature (4 °C) and was able 
to bring about a reduction in viable S. Enteritidis compared to the control. These results support 
previous reports of low temperature phage lysis of host bacteria [12]. Significant reductions in 
Salmonella counts are encouraging for their adoption for commercial use in the control of bacterial 
contamination in food products, as concluded by several studies [8,12,33], especially with foods that 
are considered sources of salmonellosis, such as poultry, eggs, and milk [35,36]. 
Environmental stability is considered a limiting factor that defines the ability of phage to sustain 
efficacy over periods of transport and storage before use in decontamination. Bacteriophage ZCSE2 
was robust in this context, with prominent stability over a range of pH conditions. Collectively, 
ZCSE2 was an efficient bacteriophage with high stability, strong lytic ability, and a broad host range 
enough to qualify it for application in the decontamination of S. enterica serovars of significance to 
human and animal health. 
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